Experts Continue Evaluating Benefits and Risks of GLP-1 Agonists
A new tailored approach to using GLP-1 receptor agonists for obesity management achieves nearly twice the weight loss.
Unlocking the Potential of GLP-1 Agonists Beyond Diabetes and Weight Loss
The pharmaceutical industry is eagerly investigating new applications for GLP-1s, but the real opportunity lies in precision medicine.
Childhood Obesity Specialists Struggle to Get GLP-1 Agonists
Here are the challenges faced by pediatric obesity specialists in accessing weight-loss meds approved by the FDA for weight loss in kids 12 years or older.
Studies Suggest GLP-1 Medications May Help Slow Progression of Some Cancers
New research suggests GLP-1 medications may help slow the progression of certain cancers and reduce mortality risk, though more studies are needed.
More on Additives and Advertising
When it comes to pouring enormous amounts of money into the economy, visual and auditory stimuli both play their parts.
GLP-1 Medications Should Be Paired With Lifestyle Modifications
Learn why lifestyle changes and tools like BrainWeighve are essential for lasting weight-loss success.
Managing Obesity With Long-Term Care
Learn how evidence-based treatments like semaglutide, tirzepatide, and GLP-1 receptor agonists are reshaping adult and pediatric obesity care.
Do I Have to Take a GLP-1 Medication Forever?
Must you take your GLP-1 medication forever to avoid weight gain and other adverse effects? Here’s what you need to know about them and life after them.
The “Miracle Drugs” Are Not Without Risk
While GLP-1RA medications offer broad health benefits, one recent study underscores that they are not without risks.
What Doctors Say About Prescribing GLP-1 Receptor Agonists to Kids
How often do doctors prescribe new weight loss drugs to kids? And what reservations and considerations drive their decisions?